Cidofovir. Review of current and potential clinical uses.
Safrin
S
S
Gilead Sciences Incorporated, Forest City, California 94404, USA.
Cherrington
J
J
Jaffe
H S
HS
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000821:virology; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000077404:Cidofovir; D002986:Clinical Trials as Topic; D003587:Cytomegalovirus / Q000187:drug effects; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy*; D003596:Cytosine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000494:pharmacology / Q000627:therapeutic use*
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir